{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:48:54Z","timestamp":1794376134772,"version":"4.9.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p><jats:italic>Proteus mirabilis<\/jats:italic> is related to serious infections. The present study was designed to investigate the minimum inhibitory concentration (MIC) of silver nanoparticles (AgNPs) and zinc oxide nanoparticles (ZnONPs) and cytotoxicity among <jats:italic>P. mirabilis<\/jats:italic> isolates recovered from clinical samples in Shiraz.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 100 <jats:italic>P. mirabilis<\/jats:italic> isolates were screened by biochemical tests and polymerase chain reaction (PCR). Also, 25 (25%) and 7 (7%) isolates were positive for extended-spectrum beta-lactamase (ESBLs) and carbapenemase, respectively. Synthesized nanoparticles were characterized by UV\u2013vis spectrum, X-ray diffraction (XRD), and electron microscopy. The average size of AgNPs and ZnONPs in the present study is 48 and &lt;\u200970\u00a0nm, respectively. The MIC and the MBC of the ZnONPs were in the range of 31.25\u00a0\u00b5g\/ml and 62.5\u00a0\u00b5g\/mL, respectively. Also, for AgNPs, the MIC and the MBC were in the range of 7.8\u00a0\u00b5g\/mL and 15.6\u00a0\u00b5g\/mL, respectively. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay in a primary culture of fibroblast L929 cells for this MIC indicated biocompatibility and low cytotoxicity of Ag NPs and for ZnONPs indicated significant cytotoxicity. Also, a MIC of AgNPs can be used as a therapeutic concentration without the effect of cytotoxicity in human cells.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-023-06402-2","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T17:12:50Z","timestamp":1706548370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Determining the cytotoxicity of the Minimum Inhibitory Concentration (MIC) of silver and zinc oxide nanoparticles in ESBL and carbapenemase producing Proteus mirabilis isolated from clinical samples in Shiraz, Southwest Iran"],"prefix":"10.1186","volume":"17","author":[{"given":"Farshad","family":"Kakian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afagh","family":"Moattari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Takallu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6430-0596","authenticated-orcid":false,"given":"Abdollah","family":"Bazargani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"6402_CR1","doi-asserted-by":"crossref","unstructured":"Armbruster CE, Mobley HL, Pearson MM. Pathogenesis of Proteus mirabilis infection. EcoSal Plus. 2018; 8; 8(1).","DOI":"10.1128\/ecosalplus.esp-0009-2017"},{"issue":"4","key":"6402_CR2","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1007\/s11033-012-2420-3","volume":"40","author":"W Adamus-Bialek","year":"2013","unstructured":"Adamus-Bialek W, Zajac E, Parniewski P, Kaca W. Comparison of antibiotic resistance patterns in collections of Escherichia coli and Proteus mirabilis uropathogenic strains. Mol Biol Rep. 2013;40(4):3429\u201335.","journal-title":"Mol Biol Rep"},{"key":"6402_CR3","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.2147\/IDR.S230303","volume":"12","author":"A Mirzaei","year":"2019","unstructured":"Mirzaei A, Habibi M, Bouzari S, Karam MR. Characterization of antibiotic-susceptibility patterns, virulence factor profiles and clonal relatedness in Proteus mirabilis isolates from patients with urinary tract infection in Iran. Infect drug Resist. 2019;12:3967.","journal-title":"Infect drug Resist"},{"issue":"2","key":"6402_CR4","first-page":"4","volume":"8","author":"JM Munita","year":"2016","unstructured":"Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microb spect. 2016;8(2):4\u20132.","journal-title":"Microb spect"},{"issue":"4","key":"6402_CR5","first-page":"778","volume":"9","author":"A Talebi Bezmin Abadi","year":"2019","unstructured":"Talebi Bezmin Abadi A, Rizvanov AA, Haertl\u00e9 T, Blatt NL. World Health Organization report: the current crisis of antibiotic resistance. Bio Nano Sci. 2019;9(4):778\u201388.","journal-title":"Bio Nano Sci"},{"key":"6402_CR6","doi-asserted-by":"crossref","unstructured":"Li X, Robinson SM, Gupta A, Saha K, Jiang Z, Moyano DF, Sahar A, Riley MA, Rotello VM. Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano. 2014; 28;8(10):10682-6.","DOI":"10.1021\/nn5042625"},{"key":"6402_CR7","doi-asserted-by":"crossref","unstructured":"Kasraei S, Sami L, Hendi S, AliKhani MY, Rezaei-Soufi L, Khamverdi Z. Antibacterial properties of composite resins incorporating silver and zinc oxide nanoparticles on Streptococcus mutans and Lactobacillus. Restor Dent Endod. 2014; 1; 39(2):109 \u2013 14.","DOI":"10.5395\/rde.2014.39.2.109"},{"key":"6402_CR8","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJN.S121956","volume":"12","author":"L Wang","year":"2017","unstructured":"Wang L, Hu C, Shao L. The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int Nanomed. 2017;12:1227.","journal-title":"Int Nanomed"},{"key":"6402_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jphotobiol.2013.01.004","volume":"5","author":"N Talebian","year":"2013","unstructured":"Talebian N, Amininezhad SM, Doudi M. Controllable synthesis of ZnO nanoparticles and their morphology-dependent antibacterial and optical properties. J Photochem Photobiol B: Biol. 2013;5:120:66\u201373.","journal-title":"J Photochem Photobiol B: Biol"},{"key":"6402_CR10","doi-asserted-by":"crossref","unstructured":"Zhang W, Niu Z, Yin K, Liu P, Chen L. Quick identification and quantification of Proteus mirabilis by polymerase chain reaction (PCR) assays. Annals Microbiol. 2013 Jun; 63(2):683\u20139.","DOI":"10.1007\/s13213-012-0520-x"},{"issue":"4","key":"6402_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1099\/jmm.0.068981-0","volume":"1","author":"I Morrissey","year":"2014","unstructured":"Morrissey I, Bouchillon SK, Hackel M, Biedenbach DJ, Hawser S, Hoban D, Badal RE. Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum \u03b2-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, and Proteus mirabilis isolates. J med Microbiol. 2014;1(4):556\u201361.","journal-title":"J med Microbiol"},{"issue":"11","key":"6402_CR12","first-page":"e01370","volume":"2","author":"M Petit","year":"2020","unstructured":"Petit M, Cam\u00e9l\u00e9na F, Cointe A, Poncin T, Merim\u00e8che M, Bonacorsi S, Birgy A, Ber\u00e7ot B. Rapid detection and characterization of carbapenemases in Enterobacterales with a new modified carbapenem inactivation method, mCIMplus. J Clin Microbiol. 2020;2(11):e01370\u201320.","journal-title":"J Clin Microbiol"},{"key":"6402_CR13","doi-asserted-by":"crossref","unstructured":"Qin Y, Ji X, Jing J, Liu H, Wu H, Yang W. Size control over spherical silver nanoparticles by ascorbic acid reduction. Colloids and Surfaces A: Physicochem Eng Asp. 2010; 3;372(1\u20133):172-6.","DOI":"10.1016\/j.colsurfa.2010.10.013"},{"key":"6402_CR14","doi-asserted-by":"crossref","unstructured":"Zaki S, El-Kady MF, Abd-El-Haleem D. Biosynthesis and structural characterization of silver nanoparticles from bacterial isolates. Mater res bull. 2011; 1;46(10):1571-6.","DOI":"10.1016\/j.materresbull.2011.06.025"},{"issue":"1","key":"6402_CR15","first-page":"105","volume":"1","author":"P Parvekar","year":"2020","unstructured":"Parvekar P, Palaskar J, Metgud S, Maria R, Dutta S. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of silver nanoparticles against Staphylococcus aureus. Biomater Investig Dent. 2020;1(1):105\u20139.","journal-title":"Biomater Investig Dent"},{"key":"6402_CR16","doi-asserted-by":"publisher","first-page":"8037","DOI":"10.2147\/IJN.S188175","volume":"13","author":"M Wang","year":"2018","unstructured":"Wang M, et al. A comparative study of toxicity of TiO2, ZnO, and Ag nanoparticles to human aortic smooth-muscle cells. Int J Nanomedicine. 2018;13:8037.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"6402_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3201\/eid2801.201928","volume":"28","author":"ML Moura","year":"2022","unstructured":"Moura ML, Boszczowski I, Blaque M, Mussarelli RM, Fossaluza V, Pierrotti LC, Campana G, Brandileone MC, Zanella R, Almeida SC, Levin AS. Effect on Antimicrobial Resistance of a policy restricting Over-the-Counter Antimicrobial sales in a large Metropolitan Area, S\u00e3o Paulo, Brazil. Emerg infects dis. 2022;28(1):180.","journal-title":"Emerg infects dis"},{"key":"6402_CR18","doi-asserted-by":"crossref","unstructured":"Gajd\u00e1cs M, Urb\u00e1n E. Comparative epidemiology and resistance trends of proteae in urinary tract infections of inpatients and outpatients: a 10-year retrospective study. Antibiotics. 2019; 11;8(3):91.","DOI":"10.3390\/antibiotics8030091"},{"issue":"1","key":"6402_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-14-1","volume":"14","author":"JT Wang","year":"2014","unstructured":"Wang JT, Chen PC, Chang SC, Shiau YR, Wang HY, Lai JF, Huang IW, Tan MC, Lauderdale TL. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program. BMC infects dis. 2014;14(1):1\u20130.","journal-title":"BMC infects dis"},{"key":"6402_CR20","unstructured":"Ahmed DA, Hasan NM. Phenotypic detection of some Beta-lactamases in local isolates of Proteus mirabilis.2022."},{"issue":"5","key":"6402_CR21","first-page":"0","volume":"8","author":"ELMGM Saleh","year":"2017","unstructured":"Saleh ELMGM. Investigation of the efficacy of synthesized silver and zinc oxide nanoparticles against multi-drug resistant gram negative bacterial clinical isolates. Arch Clin Microbiol. 2017;8(5):0.","journal-title":"Arch Clin Microbiol"},{"issue":"1","key":"6402_CR22","first-page":"97","volume":"18","author":"HQ Raheem","year":"2018","unstructured":"Raheem HQ, Al-Thahab A, Abd FG. Antibacterial activity of silver nanoparticles extracted from Proteus mirabilis and healing the wound in rabbit. Biochem Cell Arch. 2018;18(1):97\u2013104.","journal-title":"Biochem Cell Arch"},{"key":"6402_CR23","doi-asserted-by":"crossref","unstructured":"Parveen A, Yalagatti MS. Venkataraman Abbaraju, and Raghunandan Deshpande. \u201cEmphasized mechanistic antimicrobial study of biofunctionalized silver nanoparticles on model Proteus mirabilis.\u201c J drug deliv. 2018; 10(1).","DOI":"10.1155\/2018\/3850139"},{"issue":"2","key":"6402_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10787-013-0198-0","volume":"22","author":"DM Disaanayake","year":"2014","unstructured":"Disaanayake DM, Faoagali J, Laroo H, Hancock G, Whitehouse M. Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis. Inflammopharmacology. 2014;22(2):73\u20137.","journal-title":"Inflammopharmacology"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-023-06402-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-023-06402-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-023-06402-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T17:15:24Z","timestamp":1706548524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-023-06402-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6402"],"URL":"https:\/\/doi.org\/10.1186\/s13104-023-06402-2","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"assertion":[{"value":"13 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shiraz University of Medical Sciences (Ethics code: <i>IR.SUMS.REC.1400.803)<\/i>. All the participants signed the informed consent. For people under 16 years of age, informed consent was obtained from their parents or legal guardians. We followed all the ethical principles of the World Medical Association Declaration of Helsinki for medical research involving human subjects. Participants were ensured that their data will be processed by Iran\u2019s data protection laws, which ensure their confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}